Life Science M&A Transactions

Lyric Bio manufactures donor-derived and protein-based therapeutics, with an initial focus on immunoglobulin production. By leveraging proprietary tissue engineering technologies, it aims to end chronic shortages, reduce costs, and improve global drug access for life-saving medicines. Lyric Bio is based in San Francisco, California.

Meiji
Company
Life Science
Tokyo , Japan
www.meiji.com/global/pharmaceuticals

Enci Therapeutics is focused on developing therapies for cancer, heart disease, and inflammatory disorders.

Innova Therapeutics, Inc.
Company
Mt. Pleasant, South Carolina
www.innovatherapeutics.com

Plant Health Care is a biotechnology company that develops biologically-based crop-health products using patent-protected peptides to boost plant immunity, enhance stress resistance, and improve yields. Plant Health Care is based in Holly Springs, North Carolina.

PI Industries Ltd.
Company
Gurgaon, India
www.piindustries.com

Acera Surgical is a bioscience company that develops and commercialises engineered synthetic materials for soft-tissue repair and regenerative wound care. Acera Surgical was founded in 2013 and is based in St. Louis, Missouri.

Solventum
Company
Diversified
Saint Paul, Minnesota
www.solventum.com
Advisors: McDermott Will & Emery , Morgan Stanley

Exact Sciences is a molecular diagnostics company focused on the early detection and prevention of the deadliest forms of cancer. The company has exclusive intellectual property protecting its non-invasive, molecular screening technology for the detection of colorectal cancer. Exact Sciences was founded in 1995 and is based in Madison, Wisconsin.

Abbott
Company
Medical Products
North Chicago, Illinois
www.abbott.com
Advisors: Wachtell, Lipton, Rosen & Katz , Morgan Stanley

Care Fusion Rx is a speciality infusion pharmacy focused on chronic IVIG and speciality biologic therapies. Care Fusion Rx is headquartered in Garden Grove, California.

Reliant Healthcare
Company
Healthcare Services
Texarkana, Texas
www.rhcrx.com
Advisors: Bass, Berry & Sims , Brentwood Capital Advisors

Factor Bioscience's Dual-CAR T Programs are specifically designed to target patients with extramedullary disease (EMD), which we are referring to as TPST-2003 and are based in Cambridge, Massachusetts.

Tempest Therapeutics
Company
Life Science
Brisbane, California
www.tempesttx.com
Advisors: Cooley , MTS Health Partners

Factor Bioscience
Company
Life Science
Cambridge, Massachusetts
www.factor.bio

Hanmi Pharm is an R&D-centric biopharmaceutical company focusing on innovative therapies in areas such as obesity, metabolism, oncology, and rare diseases. The company also provides CDMO (contract development and manufacturing) services, supplying APIs, peptides, mRNA/biologics, and finished formulations. Hanmi Pharm was founded in 1973 and is based in Seoul, South Korea.

Aptose Biosciences
Company
Life Science
Toronto, Ontario
www.aptose.com
Advisors: McCarthy Tétrault , Locust Walk Partners

Sebela Pharmaceuticals' Bowel Prep Franchise includes prescription therapies for colonoscopy preparation and is based in Roswell, Georgia.

Azurity Pharmaceuticals
Company
Life Science
Woburn, Massachusetts
www.azurity.com
Advisors: Eversheds Sutherland , Barclays Investment Bank

Sebela Pharmaceuticals
Company
Life Science
Roswell, Georgia
www.sebelapharma.com
Advisors: Mayer Brown , Jefferies

Halda Therapeutics is a clinical-stage biotechnology company developing a novel class of cancer therapies based on its proprietary RIPTAC (Regulated Induced Proximity Targeting Chimeras) platform. The RIPTAC modality works via a “hold-and-kill” mechanism, binding a tumor-specific protein and an essential cellular protein to trigger selective cancer-cell death. Halda Therapeutics is based in New Haven, Connecticut

Johnson & Johnson
Company
Consumer Products
New Brunswick, New Jersey
www.jnj.com

Cidara Therapeutics is a biotechnology company focused on the discovery, development, and commercialization of novel anti-infectives. Cidara Therapeutics was founded in 2012 and is headquartered in San Diego, California.

Merck
Company
Life Science
Rahway, New Jersey
www.merck.com
Advisors: Gibson, Dunn & Crutcher , BofA Securities

Alcyone Therapeutics develops precision gene-based therapies for complex neurological conditions, with an emphasis on intrathecal delivery and cerebrospinal fluid-based dosing technologies. Alcyone Therapeutics was founded in 2012 and is headquartered in Lowell, Massachusetts.

Biogen
Company
Life Science
Cambridge, Massachusetts
www.biogen.com

Repare Therapeutics is a precision oncology company enabled by its proprietary synthetic lethality approach to the discovery and development of novel therapeutics. The Company utilizes its genome-wide, CRISPR-enabled SNIPRx® platform to systematically discover and develop highly targeted cancer therapies focused on genomic instability, including DNA damage repair. The Company’s pipeline includes its lead product candidate RP-3500, a potential leading ATR inhibitor, as well as CCNE1-SL inhibitor and Polθ inhibitor programs. Repare Therapeutics was founded in 2016 and is headquartered in Montreal, Quebec.

XenoTherapeutics
Company
Life Science
Boston, Massachusetts
www.xenotx.org
Advisors: Blake, Cassels & Graydon , Gibson, Dunn & Crutcher

CrownBio is a preclinical contract research organization (CRO) focused on oncology, immuno-oncology, inflammation, cardiovascular, and metabolic disease drug discovery. The firm provides in vitro, in vivo, and translational biology platforms, including patient-derived xenograft (PDX) models, organoids, and bioinformatics to help biopharmaceutical companies advance therapeutic programs. CrownBio was founded in 2006 and is headquartered in San Diego, California.

Adicon
Company
Life Science
Hangzhou, China
www.adicon.com.cn

JSR Life Sciences Corp.
Company
Life Science
Sunnyvale, California
www.jsrlifesciences.com

Mersana Therapeutics is a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. Mersana Therapeutics was founded in 2001 and is based in Cambridge, Massachusetts.

Day One
Company
Life Science
South San Francisco, California
www.dayonebio.com
Advisors: Fenwick & West , Gordon Dyal & Co. Advisory Group

Damora is a biotechnology company focused on developing therapeutic antibodies targeted at mutant calreticulin (mut-CALR)-driven myeloproliferative neoplasms (MPNs), including essential thrombocythemia (ET) and myelofibrosis (MF). Damora is based in Waltham, Massachusetts.

Galecto
Company
Life Science
Copenhagen, Denmark
www.galecto.com